nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—Bopindolol—HTR1A—bipolar disorder	0.01	0.379	CrCbGaD
Bupranolol—Penbutolol—HTR1A—bipolar disorder	0.00955	0.361	CrCbGaD
Bupranolol—Pindolol—HTR1A—bipolar disorder	0.00689	0.26	CrCbGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00176	0.0018	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00175	0.0018	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—DRD4—bipolar disorder	0.00175	0.0018	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00172	0.00177	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—DRD5—bipolar disorder	0.0017	0.00175	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.0017	0.00174	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.0017	0.00174	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—RGS4—bipolar disorder	0.00167	0.00171	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00166	0.00171	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00166	0.00171	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00164	0.00169	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—DRD2—bipolar disorder	0.00163	0.00168	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00161	0.00165	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.0016	0.00164	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00156	0.0016	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00151	0.00155	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.0015	0.00154	CbGpPWpGaD
Bupranolol—ADRB1—G alpha (s) signalling events—POMC—bipolar disorder	0.00149	0.00153	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00149	0.00153	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00148	0.00152	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00147	0.00151	CbGpPWpGaD
Bupranolol—ADRB2—G alpha (s) signalling events—POMC—bipolar disorder	0.00146	0.0015	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00145	0.00149	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00145	0.00149	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00145	0.00149	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00145	0.00149	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00142	0.00146	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00142	0.00146	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—ADM—bipolar disorder	0.00142	0.00146	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—TRPC3—bipolar disorder	0.00142	0.00146	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00141	0.00145	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—ADM—bipolar disorder	0.00139	0.00143	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—TSHB—bipolar disorder	0.00138	0.00142	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—TACR1—bipolar disorder	0.00138	0.00142	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00138	0.00141	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00137	0.0014	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—TSHB—bipolar disorder	0.00135	0.00139	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—TACR1—bipolar disorder	0.00135	0.00139	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—ADM—bipolar disorder	0.00135	0.00139	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00134	0.00137	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—PDE4B—bipolar disorder	0.00132	0.00135	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—TSHB—bipolar disorder	0.00132	0.00135	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—TACR1—bipolar disorder	0.00132	0.00135	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—TRPC3—bipolar disorder	0.00129	0.00132	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00127	0.00131	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00125	0.00128	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—ADM—bipolar disorder	0.00123	0.00126	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—DGKH—bipolar disorder	0.00121	0.00125	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.0012	0.00123	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PDE4B—bipolar disorder	0.0012	0.00123	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—TSHB—bipolar disorder	0.0012	0.00123	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—TACR1—bipolar disorder	0.0012	0.00123	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AKR1C4—bipolar disorder	0.00119	0.00123	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—DGKH—bipolar disorder	0.00119	0.00122	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HTR1A—bipolar disorder	0.00115	0.00118	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—HTR2A—bipolar disorder	0.00114	0.00118	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—TAC1—bipolar disorder	0.00113	0.00116	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HTR1A—bipolar disorder	0.00112	0.00115	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—DRD5—bipolar disorder	0.00111	0.00114	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—DRD1—bipolar disorder	0.00111	0.00114	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HTR2C—bipolar disorder	0.00111	0.00114	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—TAC1—bipolar disorder	0.0011	0.00113	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—DGKH—bipolar disorder	0.0011	0.00113	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—DGKH—bipolar disorder	0.0011	0.00113	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HTR1A—bipolar disorder	0.00109	0.00112	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—RGS4—bipolar disorder	0.00109	0.00112	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—DRD5—bipolar disorder	0.00109	0.00112	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—DRD1—bipolar disorder	0.00108	0.00111	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HTR2C—bipolar disorder	0.00108	0.00111	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—DGKH—bipolar disorder	0.00108	0.00111	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—TAC1—bipolar disorder	0.00107	0.0011	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—DRD3—bipolar disorder	0.00107	0.0011	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—RGS4—bipolar disorder	0.00107	0.00109	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—DRD1—bipolar disorder	0.00105	0.00108	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HTR2C—bipolar disorder	0.00105	0.00108	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—DRD3—bipolar disorder	0.00105	0.00108	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00104	0.00107	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—DRD4—bipolar disorder	0.00104	0.00107	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—DRD3—bipolar disorder	0.00102	0.00105	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00102	0.00105	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—DRD4—bipolar disorder	0.00102	0.00105	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—DRD5—bipolar disorder	0.00101	0.00104	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—DRD5—bipolar disorder	0.001	0.00103	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HTR1A—bipolar disorder	0.000991	0.00102	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—DRD4—bipolar disorder	0.000991	0.00102	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—RGS4—bipolar disorder	0.000989	0.00102	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—DRD5—bipolar disorder	0.000987	0.00101	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RGS4—bipolar disorder	0.000985	0.00101	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—TAC1—bipolar disorder	0.000976	0.001	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—DRD2—bipolar disorder	0.00097	0.000996	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—RGS4—bipolar disorder	0.000968	0.000994	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HTR2C—bipolar disorder	0.000957	0.000983	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—DRD1—bipolar disorder	0.000957	0.000983	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—DRD2—bipolar disorder	0.000949	0.000974	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—ADCY2—bipolar disorder	0.000933	0.000958	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—DRD3—bipolar disorder	0.000927	0.000952	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—DRD2—bipolar disorder	0.000923	0.000948	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—POMC—bipolar disorder	0.000914	0.000939	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—DRD4—bipolar disorder	0.0009	0.000924	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.000892	0.000916	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.000872	0.000896	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—ADCY2—bipolar disorder	0.000847	0.00087	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—TRPC3—bipolar disorder	0.000842	0.000865	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—DRD2—bipolar disorder	0.000838	0.000861	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—TRPC3—bipolar disorder	0.000823	0.000846	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—ADM—bipolar disorder	0.000803	0.000825	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—ADM—bipolar disorder	0.000786	0.000807	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—TACR1—bipolar disorder	0.000783	0.000804	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—TSHB—bipolar disorder	0.000783	0.000804	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PDE4B—bipolar disorder	0.000783	0.000804	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PDE4B—bipolar disorder	0.000766	0.000786	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—TSHB—bipolar disorder	0.000766	0.000786	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—TACR1—bipolar disorder	0.000766	0.000786	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—TRPC3—bipolar disorder	0.000764	0.000785	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TRPC3—bipolar disorder	0.000761	0.000782	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—TRPC3—bipolar disorder	0.000748	0.000768	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—ADM—bipolar disorder	0.000729	0.000749	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ADM—bipolar disorder	0.000726	0.000746	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—ADM—bipolar disorder	0.000713	0.000733	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.000712	0.000732	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PDE4B—bipolar disorder	0.000711	0.00073	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—TSHB—bipolar disorder	0.000711	0.00073	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—TACR1—bipolar disorder	0.000711	0.00073	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AKR1C4—bipolar disorder	0.000708	0.000727	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PDE4B—bipolar disorder	0.000707	0.000727	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TSHB—bipolar disorder	0.000707	0.000727	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TACR1—bipolar disorder	0.000707	0.000727	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.000697	0.000716	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PDE4B—bipolar disorder	0.000695	0.000714	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—TSHB—bipolar disorder	0.000695	0.000714	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—TACR1—bipolar disorder	0.000695	0.000714	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AKR1C4—bipolar disorder	0.000693	0.000711	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HTR2A—bipolar disorder	0.000679	0.000698	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HTR2A—bipolar disorder	0.000664	0.000682	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DGKH—bipolar disorder	0.000652	0.000669	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR1A—bipolar disorder	0.000648	0.000665	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HTR2A—bipolar disorder	0.000647	0.000664	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—TAC1—bipolar disorder	0.000638	0.000655	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DGKH—bipolar disorder	0.000637	0.000655	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR1A—bipolar disorder	0.000634	0.000651	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR2C—bipolar disorder	0.000626	0.000643	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—DRD1—bipolar disorder	0.000626	0.000643	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—TAC1—bipolar disorder	0.000624	0.000641	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—DRD1—bipolar disorder	0.000612	0.000629	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR2C—bipolar disorder	0.000612	0.000629	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—DRD3—bipolar disorder	0.000606	0.000622	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DRD5—bipolar disorder	0.000596	0.000612	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—DRD3—bipolar disorder	0.000593	0.000609	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR1A—bipolar disorder	0.000588	0.000604	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—DRD4—bipolar disorder	0.000588	0.000604	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HTR2A—bipolar disorder	0.000587	0.000603	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR1A—bipolar disorder	0.000586	0.000601	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RGS4—bipolar disorder	0.000584	0.0006	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DRD5—bipolar disorder	0.000583	0.000599	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—TAC1—bipolar disorder	0.000579	0.000595	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TAC1—bipolar disorder	0.000577	0.000592	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR1A—bipolar disorder	0.000575	0.000591	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—DRD4—bipolar disorder	0.000575	0.000591	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RGS4—bipolar disorder	0.000572	0.000587	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR2C—bipolar disorder	0.000568	0.000584	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—DRD1—bipolar disorder	0.000568	0.000584	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—TAC1—bipolar disorder	0.000567	0.000582	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—DRD1—bipolar disorder	0.000565	0.000581	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR2C—bipolar disorder	0.000565	0.000581	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—DRD1—bipolar disorder	0.000556	0.000571	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR2C—bipolar disorder	0.000556	0.000571	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—ADCY2—bipolar disorder	0.000554	0.000569	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—DRD3—bipolar disorder	0.00055	0.000565	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NTRK2—bipolar disorder	0.00055	0.000565	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—DRD2—bipolar disorder	0.000548	0.000563	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—DRD3—bipolar disorder	0.000548	0.000563	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GSK3A—bipolar disorder	0.000545	0.00056	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—POMC—bipolar disorder	0.000542	0.000557	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—ADCY2—bipolar disorder	0.000542	0.000556	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—DRD3—bipolar disorder	0.000538	0.000553	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—DRD2—bipolar disorder	0.000536	0.000551	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—DRD4—bipolar disorder	0.000534	0.000549	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—DRD4—bipolar disorder	0.000532	0.000546	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—POMC—bipolar disorder	0.000531	0.000545	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—DRD4—bipolar disorder	0.000523	0.000537	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—POMC—bipolar disorder	0.000516	0.00053	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—ADCY2—bipolar disorder	0.000503	0.000516	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ADCY2—bipolar disorder	0.0005	0.000514	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TCF7L2—bipolar disorder	0.000499	0.000512	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—DRD2—bipolar disorder	0.000498	0.000511	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—DRD2—bipolar disorder	0.000495	0.000509	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—ADCY2—bipolar disorder	0.000492	0.000505	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—DRD2—bipolar disorder	0.000487	0.0005	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—POMC—bipolar disorder	0.000469	0.000482	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TRPC3—bipolar disorder	0.000452	0.000464	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NTRK1—bipolar disorder	0.000448	0.000461	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TRPC3—bipolar disorder	0.000442	0.000454	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—S100B—bipolar disorder	0.000436	0.000448	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ADM—bipolar disorder	0.000431	0.000443	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ADM—bipolar disorder	0.000421	0.000433	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TACR1—bipolar disorder	0.00042	0.000431	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PDE4B—bipolar disorder	0.00042	0.000431	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TSHB—bipolar disorder	0.00042	0.000431	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PDE4B—bipolar disorder	0.000411	0.000422	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TACR1—bipolar disorder	0.000411	0.000422	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TSHB—bipolar disorder	0.000411	0.000422	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NRG1—bipolar disorder	0.000385	0.000395	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000384	0.000394	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR2A—bipolar disorder	0.000375	0.000386	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR2A—bipolar disorder	0.000349	0.000358	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR1A—bipolar disorder	0.000348	0.000357	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR2A—bipolar disorder	0.000347	0.000356	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TAC1—bipolar disorder	0.000342	0.000352	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR2A—bipolar disorder	0.000341	0.00035	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR1A—bipolar disorder	0.00034	0.000349	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR2C—bipolar disorder	0.000336	0.000345	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DRD1—bipolar disorder	0.000336	0.000345	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TAC1—bipolar disorder	0.000335	0.000344	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DRD1—bipolar disorder	0.000328	0.000337	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR2C—bipolar disorder	0.000328	0.000337	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NTRK2—bipolar disorder	0.000326	0.000335	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DRD3—bipolar disorder	0.000325	0.000334	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GSK3A—bipolar disorder	0.000324	0.000332	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NTRK2—bipolar disorder	0.000319	0.000328	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DRD3—bipolar disorder	0.000318	0.000327	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GSK3A—bipolar disorder	0.000317	0.000325	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DRD4—bipolar disorder	0.000316	0.000324	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DRD4—bipolar disorder	0.000309	0.000317	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—POMC—bipolar disorder	0.000307	0.000315	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—POMC—bipolar disorder	0.0003	0.000308	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ADCY2—bipolar disorder	0.000297	0.000305	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TCF7L2—bipolar disorder	0.000296	0.000304	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DRD2—bipolar disorder	0.000294	0.000302	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ADCY2—bipolar disorder	0.000291	0.000298	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TCF7L2—bipolar disorder	0.00029	0.000297	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DRD2—bipolar disorder	0.000288	0.000295	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GSK3B—bipolar disorder	0.000279	0.000287	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—POMC—bipolar disorder	0.000278	0.000286	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—POMC—bipolar disorder	0.000277	0.000285	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—INS—bipolar disorder	0.000276	0.000283	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—POMC—bipolar disorder	0.000272	0.00028	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NTRK1—bipolar disorder	0.000266	0.000273	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NTRK1—bipolar disorder	0.00026	0.000267	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—S100B—bipolar disorder	0.000259	0.000266	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—S100B—bipolar disorder	0.000253	0.00026	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NRG1—bipolar disorder	0.000228	0.000235	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NRG1—bipolar disorder	0.000223	0.000229	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR2A—bipolar disorder	0.000206	0.000211	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR2A—bipolar disorder	0.000201	0.000207	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GSK3B—bipolar disorder	0.000166	0.00017	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—POMC—bipolar disorder	0.000164	0.000169	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—INS—bipolar disorder	0.000164	0.000168	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GSK3B—bipolar disorder	0.000162	0.000167	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—POMC—bipolar disorder	0.000161	0.000165	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—INS—bipolar disorder	0.00016	0.000164	CbGpPWpGaD
